title: Dyslipidaemia: Failure to THRIVE: the end for niacin?
authors.forename: Anthony S
authors.initials: AS
authors.lastname: Wierzbicki
mesh_terms: D015415:Biomarkers / Q000097:blood; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D050171:Dyslipidemias / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood*; D009525:Niacin / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D007211:Indoles; D008055:Lipids; C518174:MK-0524; D009525:Niacin
references.citation: Curr Med Res Opin. 2006 Feb;22(2):417-25
references.pmid: 16466614
references.citation: JAMA. 2011 Jun 22;305(24):2556-64
references.pmid: 21693744
references.citation: N Engl J Med. 2012 Nov 29;367(22):2089-99
references.pmid: 23126252
references.citation: N Engl J Med. 2010 Apr 29;362(17):1563-74
references.pmid: 20228404
references.citation: JAMA. 1975 Jan 27;231(4):360-81
references.pmid: 1088963
references.citation: N Engl J Med. 2011 Dec 15;365(24):2255-67
references.pmid: 22085343
references.citation: Eur Heart J. 2013 May;34(17):1279-91
references.pmid: 23444397
references.citation: JAMA. 1995 Dec 13;274(22):1771-4
references.pmid: 7500507
references.citation: Lancet. 2010 Nov 13;376(9753):1670-81
references.pmid: 21067804